Generative synthetic intelligence (GenAI) is already altering how individuals analysis, talk, and work together, however its largest impacts on biotech are nonetheless to come back.
Cradle is a Dutch-Swiss biotech startup based in 2021 that has developed a web-based software program platform leveraging GenAI to speed up protein design and optimization, aiding scientists in biotechnology R&D. Cradle’s know-how integrates AI with moist lab experimentation, doubling the velocity of most tasks in comparison with business benchmarks.
On this episode I discuss to Cradle co-founder Elise de Reus to find how their software program platform is placing the ‘tech’ into biotech, and learn the way a number of the largest names in pharma R&D are coming to depend on Cradle to speed up their experimentation and get therapies to sufferers quicker.
01:30 A ardour for biotech from a younger age
03:20 First experiences within the business
07:23 Cradle and its mission
09:08 Generative AI at Cradle
10:27 Partnering and collaborations
13:37 Taking generative AI into the moist lab
14:43 A techbio firm, not a biotech firm
17:36 “Photoshop for proteins”
18:29 Use case: animal free meals
20:17 Use case: medicines
23:56 Use case: sustainable supplies
25:12 The Cradle enterprise mannequin
28:17 Technical challenges
29:48 Regulatory challenges
31:44 The place AI could have the best influence
33:29 Essentially the most thrilling issues to come back
Focused on being a sponsor of an episode of our podcast? Uncover how one can become involved right here!
Keep up to date by subscribing to our publication
To dive deeper into the subject:
A ardour for biotech from a younger age
First experiences within the business
Partnering and collaborations
Taking generative AI into the moist lab
A techbio firm, not a biotech firm
“Photoshop for proteins”
Use case: animal free meals
Use case: sustainable supplies
The Cradle enterprise mannequin
The place AI could have the best influence
Essentially the most thrilling issues to come back
